Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 8 November 1991:
Vol. 254. no. 5033, pp. 815 - 820
DOI: 10.1126/science.1658933
Prev | Table of Contents | Next

Articles

Science, Vol 254, Issue 5033, 815-820
Copyright © 1991 by American Association for the Advancement of Science

articles

Molecular basis of latency in pathogenic human viruses

MA Garcia-Blanco and BR Cullen

Section of Cell Growth, Regulation, and Oncogenesis, Duke University Medical Center, Durham, NC 27710.

Several human viruses are able to latently infect specific target cell populations in vivo. Analysis of the replication cycles of herpes simplex virus, Epstein-Barr virus, and human immunodeficiency virus suggests that the latent infections established by these human pathogens primarily result from a lack of host factors critical for the expression of viral early gene products. The subsequent activation of specific cellular transcription factors in response to extracellular stimuli can induce the expression of these viral regulatory proteins and lead to a burst of lytic viral replication. Latency in these eukaryotic viruses therefore contrasts with latency in bacteriophage, which is maintained primarily by the expression of virally encoded repressors of lytic replication.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones.
J. T. Proenca, H. M. Coleman, V. Connor, D. J. Winton, and S. Efstathiou (2008)
J. Gen. Virol. 89, 2965-2974
   Abstract »    Full Text »    PDF »
Lentivirus vectors expressing short hairpin RNAs against the U3-overlapping region of HIV nef inhibit HIV replication and infectivity in primary macrophages.
T. Yamamoto, H. Miyoshi, N. Yamamoto, N. Yamamoto, J.-i. Inoue, and Y. Tsunetsugu-Yokota (2006)
Blood 108, 3305-3312
   Abstract »    Full Text »    PDF »
Anti-Human Immunodeficiency Virus Type 1 Microbicide Cellulose Acetate 1,2-Benzenedicarboxylate in a Human In Vitro Model of Vaginal Inflammation.
R. N. Fichorova, F. Zhou, V. Ratnam, V. Atanassova, S. Jiang, N. Strick, and A. R. Neurath (2005)
Antimicrob. Agents Chemother. 49, 323-335
   Abstract »    Full Text »    PDF »
Interleukin (IL)-1, IL-6, and IL-8 Predict Mucosal Toxicity of Vaginal Microbicidal Contraceptives.
R.N. Fichorova, M. Bajpai, N. Chandra, J.G. Hsiu, M. Spangler, V. Ratnam, and G.F. Doncel (2004)
Biol Reprod 71, 761-769
   Abstract »    Full Text »    PDF »
Candidate Topical Microbicides Bind Herpes Simplex Virus Glycoprotein B and Prevent Viral Entry and Cell-to-Cell Spread.
N. Cheshenko, M. J. Keller, V. MasCasullo, G. A. Jarvis, H. Cheng, M. John, J.-H. Li, K. Hogarty, R. A. Anderson, D. P. Waller, et al. (2004)
Antimicrob. Agents Chemother. 48, 2025-2036
   Abstract »    Full Text »    PDF »
Rigorous pre-clinical evaluation of topical microbicides to prevent transmission of human immunodeficiency virus.
M. J. Keller, M. E. Klotman, and B. C. Herold (2003)
J. Antimicrob. Chemother. 51, 1099-1102
   Full Text »    PDF »
Neurons Differentially Activate the Herpes Simplex Virus Type 1 Immediate-Early Gene ICP0 and ICP27 Promoters in Transgenic Mice.
C. M. Loiacono, R. Myers, and W. J. Mitchell (2002)
J. Virol. 76, 2449-2459
   Abstract »    Full Text »    PDF »
Mechanisms of Central Nervous System Viral Persistence: the Critical Role of Antibody and B Cells.
C. Ramakrishna, S. A. Stohlman, R. D. Atkinson, M. J. Shlomchik, and C. C. Bergmann (2002)
J. Immunol. 168, 1204-1211
   Abstract »    Full Text »    PDF »
NF-kappa B cis-Acting Motifs of the Human Immunodeficiency Virus (HIV) Long Terminal Repeat Regulate HIV Transcription in Human Macrophages.
S. Asin, G. D. Bren, E. M. Carmona, N. J. Solan, and C. V. Paya (2001)
J. Virol. 75, 11408-11416
   Abstract »    Full Text »
The Transgenic ICP4 Promoter Is Activated in Schwann Cells in Trigeminal Ganglia of Mice Latently Infected with Herpes Simplex Virus Type 1.
N. S. Taus and W. J. Mitchell (2001)
J. Virol. 75, 10401-10408
   Abstract »    Full Text »    PDF »
ERK MAP Kinase Links Cytokine Signals to Activation of Latent HIV-1 Infection by Stimulating a Cooperative Interaction of AP-1 and NF-kappa B.
X. Yang, Y. Chen, and D. Gabuzda (1999)
J. Biol. Chem. 274, 27981-27988
   Abstract »    Full Text »    PDF »
Antibody Prevents Virus Reactivation Within the Central Nervous System.
M. T. Lin, D. R. Hinton, N. W. Marten, C. C. Bergmann, and S. A. Stohlman (1999)
J. Immunol. 162, 7358-7368
   Abstract »    Full Text »    PDF »
Regulation of Human Immunodeficiency Virus Type 1 Infectivity by the ERK Mitogen-Activated Protein Kinase Signaling Pathway.
X. Yang and D. Gabuzda (1999)
J. Virol. 73, 3460-3466
   Abstract »    Full Text »
Persistent Hz-1 Virus Infection in Insect Cells: Evidence for Insertion of Viral DNA into Host Chromosomes and Viral Infection in a Latent Status.
C.-L. Lin, J.-C. Lee, S.-S. Chen, H. Alan Wood, M.-L. Li, C.-F. Li, and Y.-C. Chao (1999)
J. Virol. 73, 128-139
   Abstract »    Full Text »    PDF »
The Polyserine Tract of Herpes Simplex Virus ICP4 Is Required for Normal Viral Gene Expression and Growth in Murine Trigeminal Ganglia.
P. A. Bates and N. A. DeLuca (1998)
J. Virol. 72, 7115-7124
   Abstract »    Full Text »    PDF »
Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency.
O. Lungu, C. A. Panagiotidis, P. W. Annunziato, A. A. Gershon, and S. J. Silverstein (1998)
PNAS 95, 7080-7085
   Abstract »    Full Text »    PDF »
Acquired Immunodeficiency Syndrome-- A Review and Update: History, Characteristics of Human Immunodeficiency Virus Infection, Its Replication, Biologic Factors, and Pathogenicity.
N. W. Fox and C. P. McArthur (1993)
Arch Fam Med 2, 1068-1077
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)